BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

660 related articles for article (PubMed ID: 23726902)

  • 1. Prognosis following local recurrence after breast conserving treatment in young women with early breast cancer.
    van der Sangen MJ; Poortmans PM; Scheepers SW; Lemaire BM; van Berlo CL; Tjan-Heijnen VC; Voogd AC
    Eur J Surg Oncol; 2013 Aug; 39(8):892-8. PubMed ID: 23726902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer.
    Galper S; Blood E; Gelman R; Abner A; Recht A; Kohli A; Wong JS; Smith D; Bellon J; Connolly J; Schnitt S; Winer E; Silver B; Harris JR
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):348-57. PubMed ID: 15667952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local recurrence following breast-conserving treatment in women aged 40 years or younger: trends in risk and the impact on prognosis in a population-based cohort of 1143 patients.
    van Laar C; van der Sangen MJ; Poortmans PM; Nieuwenhuijzen GA; Roukema JA; Roumen RM; Tjan-Heijnen VC; Voogd AC
    Eur J Cancer; 2013 Oct; 49(15):3093-101. PubMed ID: 23800672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
    Sanpaolo P; Barbieri V; Genovesi D
    Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy boost dose-escalation for invasive breast cancer after breast-conserving surgery: 2093 patients treated with a prospective margin-directed policy.
    Livi L; Meattini I; Franceschini D; Saieva C; Meacci F; Marrazzo L; Gerlain E; Desideri I; Scotti V; Nori J; Sanchez LJ; Orzalesi L; Bonomo P; Greto D; Bianchi S; Biti G
    Radiother Oncol; 2013 Aug; 108(2):273-8. PubMed ID: 23490271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates: a 14-year report from a comprehensive cancer center.
    Dragun AE; Pan J; Riley EC; Kruse B; Wilson MR; Rai S; Jain D
    Am J Clin Oncol; 2013 Aug; 36(4):375-80. PubMed ID: 22643566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge.
    Cabioglu N; Krishnamurthy S; Kuerer HM; Hunt KK; Singletary SE; Meric-Bernstam F; Ross MI; Feig BW; Ames FC; Babiera GV
    Cancer; 2004 Aug; 101(3):508-17. PubMed ID: 15274063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Who should not undergo breast conservation?
    Nijenhuis MV; Rutgers EJ
    Breast; 2013 Aug; 22 Suppl 2():S110-4. PubMed ID: 24074770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local recurrence after breast-conserving surgery: multivariable analysis of risk factors and the impact of young age.
    Miles RC; Gullerud RE; Lohse CM; Jakub JW; Degnim AC; Boughey JC
    Ann Surg Oncol; 2012 Apr; 19(4):1153-9. PubMed ID: 21989658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The long-term prognosis of locally recurrent breast cancer after breast conserving treatment].
    Voogd AC; Rutgers EJ; van Tienhoven G
    Ned Tijdschr Geneeskd; 2006 Jan; 150(1):29-33. PubMed ID: 16440622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.
    Donker M; Litière S; Werutsky G; Julien JP; Fentiman IS; Agresti R; Rouanet P; de Lara CT; Bartelink H; Duez N; Rutgers EJ; Bijker N
    J Clin Oncol; 2013 Nov; 31(32):4054-9. PubMed ID: 24043739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy omission after breast-conserving surgery is associated with reduced breast cancer-specific survival in elderly women with breast cancer.
    Truong PT; Bernstein V; Lesperance M; Speers CH; Olivotto IA
    Am J Surg; 2006 Jun; 191(6):749-55. PubMed ID: 16720143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: multicentric study of the GEC-ESTRO Breast Cancer Working Group.
    Hannoun-Levi JM; Resch A; Gal J; Kauer-Dorner D; Strnad V; Niehoff P; Loessl K; Kovács G; Van Limbergen E; Polgár C;
    Radiother Oncol; 2013 Aug; 108(2):226-31. PubMed ID: 23647758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early response to neo-adjuvant chemotherapy in carcinoma of the breast predicts both successful breast-conserving surgery and decreased risk of ipsilateral breast tumor recurrence.
    Ishitobi M; Komoike Y; Motomura K; Koyama H; Inaji H
    Breast J; 2010; 16(1):9-13. PubMed ID: 19929889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy.
    Margalit DN; Sreedhara M; Chen YH; Catalano PJ; Nguyen PL; Golshan M; Overmoyer BA; Harris JR; Brock JE
    Ann Surg Oncol; 2013 Mar; 20(3):811-8. PubMed ID: 22956068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-stage young breast cancer patients: impact of local treatment on survival.
    Bantema-Joppe EJ; de Munck L; Visser O; Willemse PH; Langendijk JA; Siesling S; Maduro JH
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e553-9. PubMed ID: 21601378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.
    Komoike Y; Akiyama F; Iino Y; Ikeda T; Akashi-Tanaka S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
    Cancer; 2006 Jan; 106(1):35-41. PubMed ID: 16333848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European Organisation for Research and Treatment of Cancer studies.
    de Bock GH; van der Hage JA; Putter H; Bonnema J; Bartelink H; van de Velde CJ
    Eur J Cancer; 2006 Feb; 42(3):351-6. PubMed ID: 16314086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does local recurrence affect the rate of distant metastases and survival in patients with early-stage breast carcinoma treated with breast-conserving therapy?
    Vicini FA; Kestin L; Huang R; Martinez A
    Cancer; 2003 Feb; 97(4):910-9. PubMed ID: 12569590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.